Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome

Cover Page

Abstract


The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and obesity. The antihypertensive efficacy of aliskiren in combination with valsartan was demonstrated as dose-dependent, and was well tolerated and high safety of this combination therapy.

O V Dralova

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

M L Maximov

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

A S Ermolaeva

I.M. Sechenov MMA

Кафедра клинической фармакологиии пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA

Views

Abstract - 534

PDF (Russian) - 38


Copyright (c) 2010 Дралова О.В., Максимов М.Л., Ермолаева А.С.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.